ORKA insider transactions
Oruka Therapeutics Inc. (ORKA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ORKA
- SEC Form 4 filed by Goncalves Joana4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Executive Officer Klein Lawrence Otto sold $71,408 worth of shares (1,729 units at $41.30), decreasing direct ownership by 0.19% to 927,309 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Senior Vice President, Finance Agarwal Arjun sold $16,313 worth of shares (395 units at $41.30), decreasing direct ownership by 2% to 18,863 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Operating Officer Sandler Laura Lee sold $24,780 worth of shares (600 units at $41.30), decreasing direct ownership by 0.25% to 236,984 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Medical Officer Goncalves Joana exercised 7,000 shares at a strike of $7.32 and sold $312,560 worth of shares (7,641 units at $40.91), decreasing direct ownership by 2% to 33,377 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- General Counsel Quinlan Paul T sold $30,273 worth of shares (733 units at $41.30), decreasing direct ownership by 2% to 31,767 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Operating Officer Sandler Laura Lee sold $167,822 worth of shares (5,000 units at $33.56) and exercised 5,000 shares at a strike of $7.80 (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Medical Officer Goncalves Joana exercised 7,000 shares at a strike of $7.32 and sold $226,559 worth of shares (7,000 units at $32.37) (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Medical Officer Goncalves Joana was granted 32,500 shares, increasing direct ownership by 2,141% to 34,018 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Operating Officer Sandler Laura Lee was granted 32,500 shares, increasing direct ownership by 16% to 237,584 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SVP, Finance Agarwal Arjun was granted 17,500 shares, increasing direct ownership by 995% to 19,258 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Executive Officer Klein Lawrence Otto was granted 76,700 shares, increasing direct ownership by 9% to 929,038 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- General Counsel Quinlan Paul T was granted 32,500 shares (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Director Dambkowski Carl acquired 116,483 shares (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Medical Officer Goncalves Joana exercised 7,000 shares at a strike of $7.32 and sold $222,704 worth of shares (7,000 units at $31.81) (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Operating Officer Sandler Laura Lee exercised 5,000 shares at a strike of $7.80 and sold $370,795 worth of shares (13,000 units at $28.52), decreasing direct ownership by 4% to 205,084 units (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Chief Medical Officer Goncalves Joana exercised 7,000 shares at a strike of $7.32 and sold $214,293 worth of shares (7,000 units at $30.61) (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by Director Martin Christopher Nathan4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 3 filed by new insider Martin Christopher Nathan3 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Director Fairmount Funds Management Llc was granted 333,340 shares (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Sandler Laura Lee4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- New insider Sandler Laura Lee claimed ownership of 213,084 shares (SEC Form 3)3 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by Director Fairmount Funds Management Llc4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by Director Kulkarni Samarth4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by Director Dambkowski Carl4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by Director Turtle Cameron4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by Director Ball Kristine M4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Large owner Venrock Healthcare Capital Partners Iii, L.P. bought $1,407,368 worth of shares (122,882 units at $11.45) (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- New insider Venrock Healthcare Capital Partners Iii, L.P. claimed ownership of 4,025,546 shares (SEC Form 3)3 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by SVP, Finance Agarwal Arjun4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Goncalves Joana4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by General Counsel Quinlan Paul T4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Klein Lawrence Otto4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)
- Director Fairmount Funds Management Llc converted options into 160,000 shares (SEC Form 4)4 - Oruka Therapeutics, Inc. (0000907654) (Issuer)